| Report ID | Date of report | Patient age | Patient gender |
| 81027 | Mar, 22, 2006 | 64 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Sotalol Hydrochloride | sotalol hydrochloride |
Verapamil | verapamil hydrochloride |
Digoxin | digoxin |
Warfarin Sodium | warfarin sodium |
| Name |
Abdominal Pain |
Atrial Fibrillation |
Blood Sodium Decreased |
Bradycardia |
Cardioactive Drug Level Decreased |
Cardiomegaly |
Cough |
Depressed Level Of Consciousness |
Drug Ineffective |
Drug Interaction Potentiation |
Dyspnoea |
Haemodialysis |
Heart Rate Increased |
Hypotension |
International Normalised Ratio Increased |
Livedo Reticularis |
Liver Function Test Abnormal |
Metabolic Acidosis |
Renal Failure |
Respiratory Rate Increased |
Resuscitation |
Results from eHealthMe : 35 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Abdominal Pain | 7 (20.00%) |
Atrial Fibrillation | 28 (80.00%) |
Blood Sodium Decreased | 2 (5.71%) |
Bradycardia | 29 (82.86%) |
Cardioactive Drug Level Decreased | 21 (60.00%) |
Cardiomegaly | 24 (68.57%) |
Cough | 18 (51.43%) |
Depressed Level Of Consciousness | 25 (71.43%) |
Drug Ineffective | 4 (11.43%) |
Drug Interaction Potentiation | 3 (8.57%) |
Dyspnoea | 19 (54.29%) |
Haemodialysis | 9 (25.71%) |
Heart Rate Increased | 5 (14.29%) |
Hypotension | 29 (82.86%) |
International Normalised Ratio Increased | 7 (20.00%) |
Livedo Reticularis | 23 (65.71%) |
Liver Function Test Abnormal | 23 (65.71%) |
Metabolic Acidosis | 29 (82.86%) |
Renal Failure | 23 (65.71%) |
Respiratory Rate Increased | 6 (17.14%) |
Resuscitation | 1 (2.86%) |
Top 3 (total: 43. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Perindopril Erbumine | 23 (10.60%) |
Sotalol Hcl | 11 (5.07%) |
Coumadin | 4 (1.84%) |
Death reported: 0
| Name | Count (% of total reports) |
Hypotension | 29 (82.86%) |
Metabolic Acidosis | 29 (82.86%) |
Bradycardia | 29 (82.86%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
